The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: "ehsl_novel_nam"
1 - 25 of 3
| Title | Creator | Description | Identifier | ||
|---|---|---|---|---|---|
| 1 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (Video) | Eduardo Nicolás Seleme, Michel Sun, John Chen, Anastasia Zekeridou, Elia Sechi, Ryan Walsh, Johanna Beebe, Osama Sabbagh, Luis Mejico, Sean Gratton, Philip Skidd, David Bellows, Julie Falardeau, Clare Fraser, Cecilia Cappelen-Smith, Scott Haines, Bahareh Hassanzadeh, Meagan Seay, Prem Subramanian, ... | In recent years, the use of CTLA-4 and PD-1/PD-L1 checkpoint blockade inhibitors have proven to be effective and become increasingly widespread treatment options for metastatic melanoma and other cancers by enhancing autologous anti-tumor immune responses. Immune related ophthalmologic complications... | 20200309_nanos_sciplatform1_05 |
| 2 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (Slides) | Eduardo Nicolás Seleme, Michel Sun, John Chen, Anastasia Zekeridou, Elia Sechi, Ryan Walsh, Johanna Beebe, Osama Sabbagh, Luis Mejico, Sean Gratton, Philip Skidd, David Bellows, Julie Falardeau, Clare Fraser, Cecilia Cappelen-Smith, Scott Haines, Bahareh Hassanzadeh, Meagan Seay, Prem Subramanian, ... | In recent years, the use of CTLA-4 and PD-1/PD-L1 checkpoint blockade inhibitors have proven to be effective and become increasingly widespread treatment options for metastatic melanoma and other cancers by enhancing autologous anti-tumor immune responses. Immune related ophthalmologic complications... | 20200309_nanos_sciplatform1_05-slides |
| 3 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (PDF) | Eduardo Nicolás Seleme, Michel Sun, John Chen, Anastasia Zekeridou, Elia Sechi, Ryan Walsh, Johanna Beebe, Osama Sabbagh, Luis Mejico, Sean Gratton, Philip Skidd, David Bellows, Julie Falardeau, Clare Fraser, Cecilia Cappelen-Smith, Scott Haines, Bahareh Hassanzadeh, Meagan Seay, P... | In recent years, the use of CTLA-4 and PD-1/PD-L1 checkpoint blockade inhibitors have proven to be effective and become increasingly widespread treatment options for metastatic melanoma and other cancers by enhancing autologous anti-tumor immune responses. Immune related ophthalmologic complications... | 20200309_nanos_sciplatform1_05-pdf |
1 - 25 of 3